Industry Educational Session - How is the evolving Multiple Myeloma therapeutic landscape changing treatment decision making? - Sponsored by Janssen
Tracks
Track 4
| Monday, April 29, 2024 |
| 2:15 PM - 3:00 PM |
| Room 3B |
Details
A symposium discussing the evolution of treatment choices in Multiple Myeloma and the impact this has on clinical decision making. Themes that will be covered by the panel are transplant eligibility, class refractoriness and sequencing strategies. Throughout the presentation there will be opportunity for audience participation as well as a Q&A session chaired by one of the panel.
This promotional symposium is fully developed and funded by Janssen for UK healthcare professionals only. Janssen products will be discussed, and prescribing information and adverse event reporting will be available at the meeting.
Job bag: CP-442062 Date of prep: April 2024
Speaker
Dr. Kevin Boyd
Consultant Haematologist
The Royal Marsden Nhs Foundation Trust
-
Dr. Andrew Charlton
Consultant
Newcastle Hospitals
-
Dr. Fenella Willis
Consultant Haematologist
St George's Hospital
-
